Seagen Inc. Insider Trading for August 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for August 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 39.15 | 157,446 | 6,164,011 | 157,446 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 64,000 | 0 | 611,323 | 547.3 K to 611.3 K (+11.69 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 42.02 | 31,754 | 1,334,440 | 525,268 | 557 K to 525.3 K (-5.70 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 44,946 | 1,759,636 | 44,946 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 4,688 | 96,198 | 0 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 245 | 3,788 | 0 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 19,000 | 0 | 98,340 | 79.3 K to 98.3 K (+23.95 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 245 | 3,788 | 79,340 | 79.1 K to 79.3 K (+0.31 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 4,688 | 96,198 | 79,095 | 74.4 K to 79.1 K (+6.30 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.02 | 8,548 | 359,226 | 74,407 | 83 K to 74.4 K (-10.30 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 39.15 | 47,446 | 1,857,511 | 47,446 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 20,000 | 0 | 82,724 | 62.7 K to 82.7 K (+31.89 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 42.02 | 4,462 | 187,513 | 62,724 | 67.2 K to 62.7 K (-6.64 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Option Exercise | A | 39.15 | 27,780 | 1,087,587 | 27,780 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Option Exercise | A | 39.15 | 2,220 | 86,913 | 2,220 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Grant | A | 0.00 | 12,000 | 0 | 43,482 | 31.5 K to 43.5 K (+38.12 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Sell | S | 42.02 | 2,231 | 93,757 | 31,482 | 33.7 K to 31.5 K (-6.62 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | A | 39.15 | 39,946 | 1,563,886 | 39,946 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Grant | A | 0.00 | 17,000 | 0 | 179,874 | 162.9 K to 179.9 K (+10.44 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 42.02 | 5,825 | 244,794 | 162,874 | 168.7 K to 162.9 K (-3.45 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Option Exercise | A | 39.15 | 32,446 | 1,270,261 | 32,446 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Grant | A | 0.00 | 14,000 | 0 | 36,400 | 22.4 K to 36.4 K (+62.50 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Option Exercise | A | 39.15 | 34,946 | 1,368,136 | 34,946 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Grant | A | 0.00 | 15,000 | 0 | 76,212 | 61.2 K to 76.2 K (+24.50 %) |
| Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Sell | S | 42.02 | 5,997 | 252,021 | 61,212 | 67.2 K to 61.2 K (-8.92 %) |
| Aug 07 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 5.63 | 3,718 | 20,932 | 14,874 | |
| Aug 07 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 46.91 | 3,718 | 174,411 | 557,022 | 560.7 K to 557 K (-0.66 %) |
| Aug 07 2015 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.63 | 3,718 | 20,932 | 560,740 | 557 K to 560.7 K (+0.67 %) |